Analyst Activity – Jefferies Group Raises Its Price Target On AxoGen (NASDAQ:AXGN) to

Analyst Ratings For AxoGen (NASDAQ:AXGN)

Story continues below

Today, Jefferies Group raised its price target on AxoGen (NASDAQ:AXGN) to per share.

Some recent analyst ratings include

  • 2/5/2018-William Blair initiated coverage with a Outperform rating.
  • 11/21/2017-Wedbush Reiterated Rating of Buy.

Recent Insider Trading Activity For AxoGen (NASDAQ:AXGN)
AxoGen (NASDAQ:AXGN) has insider ownership of 9.33% and institutional ownership of 67.97%.

  • On 2/20/2018 Jamie Mark Grooms, Director, sold 63,395 with an average share price of $27.67 per share and the total transaction amounting to $1,754,139.65.
  • On 2/15/2018 Jamie Mark Grooms, CFO, sold 95,712 with an average share price of $26.84 per share and the total transaction amounting to $2,568,910.08.
  • On 2/13/2018 Jamie Mark Grooms, CFO, sold 10,300 with an average share price of $26.21 per share and the total transaction amounting to $269,963.00.
  • On 12/12/2017 Jamie Mark Grooms, Director, sold 38,405 with an average share price of $26.35 per share and the total transaction amounting to $1,011,971.75.
  • On 12/8/2017 Jamie Mark Grooms, Director, sold 84,295 with an average share price of $26.38 per share and the total transaction amounting to $2,223,702.10.
  • On 12/6/2017 Jamie Mark Grooms, Director, sold 21,290 with an average share price of $26.22 per share and the total transaction amounting to $558,223.80.
  • On 11/20/2017 Guido J Neels, Director, sold 1,150,000 with an average share price of $19.74 per share and the total transaction amounting to $22,701,000.00.

Recent Trading Activity for AxoGen (NASDAQ:AXGN)
Shares of AxoGen closed the previous trading session at with 39.0 shares trading hands.

An ad to help with our costs